Literature DB >> 6511230

Preservative alteration of corneal permeability in humans and rabbits.

N L Burstein.   

Abstract

Isotonic, neutral buffered solutions of benzalkonium chloride or chlorhexidine digluconate were applied topically to one eye of rabbits or human subjects. Contralateral control eyes received phosphate buffered saline as placebo. One-half hour later, the tear film of both eyes was loaded with nonpreserved sodium fluorescein. Anterior chamber fluorescence levels were measured at 1 hr intervals to determine corneal permeability changes attributable to preservative action. In rabbits, corneal permeability increased with rising preservative concentration. Benzalkonium chloride 0.01% increased anterior chamber fluorescence level 1.8 (+/- 0.2 SEM) times over control eyes, while chlorhexidine digluconate 0.01% caused 1.5 (+/- 0.2 SEM) to one ratio of fluorescence in treated/untreated eyes. In human subjects, neither preservative produced significant permeability change at 0.01% concentration. However, benzalkonium chloride 0.02% caused 1.23 (+/- 0.08 SEM) permeability increase. The results support the hypothesis that rabbits are more sensitive to single-dose applications of preservatives than humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511230

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.

Authors:  Dörte von Deylen; Christina Dreher; Oliver Seidelmann; Stephan Reichl
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

2.  The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.

Authors:  Arash Kazemi; Jay W McLaren; Casey C Kopczynski; Theresa G Heah; Gary D Novack; Arthur J Sit
Journal:  J Ocul Pharmacol Ther       Date:  2018-02-22       Impact factor: 2.671

3.  Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures.

Authors:  Ramez I Haddadin; Dong-Jin Oh; Min Hyung Kang; Guadalupe Villarreal; Ja-Heon Kang; Rui Jin; Haiyan Gong; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-28       Impact factor: 4.799

4.  AMP-activated protein kinase regulates intraocular pressure, extracellular matrix, and cytoskeleton in trabecular meshwork.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Dong-Jin Oh; Min Hyung Kang; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-08       Impact factor: 4.799

5.  Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery.

Authors:  H Eleftheriadis; M Cheong; S Sandeman; P P Syam; P Brittain; G K Klintworth; A Lloyd; C Liu
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

6.  Topical timolol with and without benzalkonium chloride: epithelial permeability and autofluorescence of the cornea in glaucoma.

Authors:  C de Jong; T Stolwijk; E Kuppens; R de Keizer; J van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

7.  Topical timolol, corneal epithelial permeability and autofluorescence in glaucoma by fluorophotometry.

Authors:  E Kuppens; T Stolwijk; J van Best; R de Keizer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

8.  Niosome-encapsulated gentamicin for ophthalmic controlled delivery.

Authors:  Ghada Abdelbary; Nashwa El-Gendy
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

9.  Effects of artificial tears on corneal epithelial permeability in dry eyes.

Authors:  M Göbbels; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

10.  Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.

Authors:  Sakshi Malhotra; Anubha Khare; Kanchan Grover; Inderbir Singh; Pravin Pawar
Journal:  J Pharm (Cairo)       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.